Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man
- PMID: 6768762
- DOI: 10.1210/jcem-50-6-1011
Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man
Abstract
Plasma PRL fell in nine healthy subjects and four patients with hyperprolactinemia after iv administration of salmon calcitonin (CT). The maximum fall was observed 30--60 min after the infusion. There was no change in the plasma concentrations of the other anterior pituitary hormones tested (GH, FSH, LH, and TSH). In five healthy subjects, TRH was injected 60 min after the CT infusion. This protocol was repeated in the same subjects at 3-day intervals, except CT was not administered. Plasma PRL before TRH injection was clearly lower when CT had been administered. Plasma concentrations of the other anterior pituitary hormones did not change. PRL and TSH responses to TRH were markedly inhibited when CT had been previously infused. These observations are in agreement with preceeding studies showing a similar effect of CT on the plasma concentration of various other polypeptide hormones. This general effect of CT could be attributed to a change in intracellular calcium of the secreting cells.
Similar articles
-
Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.J Clin Endocrinol Metab. 1986 May;62(5):892-8. doi: 10.1210/jcem-62-5-892. J Clin Endocrinol Metab. 1986. PMID: 3007559
-
Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.J Clin Endocrinol Metab. 1985 Apr;60(4):623-30. doi: 10.1210/jcem-60-4-623. J Clin Endocrinol Metab. 1985. PMID: 2982903
-
Effects of dopamine infusion on pituitary hormone secretion in humans.J Clin Endocrinol Metab. 1976 Sep;43(3):668-74. doi: 10.1210/jcem-43-3-668. J Clin Endocrinol Metab. 1976. PMID: 956350
-
The relationship of sleep and sleep stages to neuroendocrine secretion and biological rhythms in man.Recent Prog Horm Res. 1975;31:399-446. doi: 10.1016/b978-0-12-571131-9.50015-3. Recent Prog Horm Res. 1975. PMID: 172995 Review. No abstract available.
-
Endocrine evaluation of hyperprolactinemia.Clin Obstet Gynecol. 1980 Jun;23(2):349-65. doi: 10.1097/00003081-198006000-00007. Clin Obstet Gynecol. 1980. PMID: 6772367 Review. No abstract available.
Cited by
-
Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):463-98. doi: 10.1007/BF03259897. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063922 Review.
-
Does calcitonin modulate anterior pituitary hormone secretion?J Endocrinol Invest. 1982 Sep-Oct;5(5):327-30. doi: 10.1007/BF03350522. J Endocrinol Invest. 1982. PMID: 6818271
-
Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.J Endocrinol Invest. 1985 Apr;8(2):103-6. doi: 10.1007/BF03350657. J Endocrinol Invest. 1985. PMID: 3928730
-
Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.J Endocrinol Invest. 1989 Jan;12(1):25-9. doi: 10.1007/BF03349910. J Endocrinol Invest. 1989. PMID: 2545765 Clinical Trial.
-
Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.Calcif Tissue Int. 1985 Dec;37(6):687-9. doi: 10.1007/BF02554932. Calcif Tissue Int. 1985. PMID: 3937596
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical